Refractory Classic Hodgkin Lymphoma

specific

A classic Hodgkin lymphoma that is resistant to treatment.

18

Centers

2

Active Trials

—

Cancer Funding

Top Centers for Refractory Classic Hodgkin Lymphoma(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Dana-Farber Cancer InstituteBoston, MA
NCI Comprehensive
High-Volume Research Center
72.8
2
Stanford Cancer InstitutePalo Alto, CA
NCI Comprehensive
High-Volume Research Center
72.8
3
Memorial Sloan Kettering Cancer CenterNew York, NY
NCI Comprehensive
50.3
4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins UniversityBaltimore, MD
NCI Comprehensive
50.3
5
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
50.3
6
UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC
NCI Comprehensive
50.3
7
UC San Diego Moores Cancer CenterLa Jolla, CA
NCI Comprehensive
50.3
8
Dan L Duncan Comprehensive Cancer Center at Baylor College of MedicineHouston, TX
NCI Comprehensive
50.3
9
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
50.3
10
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
50.3
11
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
50.3
12
Montefiore Einstein Comprehensive Cancer CenterBronx, NY
NCI Comprehensive
50.3
13
UC Davis Comprehensive Cancer CenterSacramento, CA
NCI Comprehensive
50.3
14
University of Virginia Cancer CenterCharlottesville, VA
NCI Comprehensive
50.3
15
Sylvester Comprehensive Cancer CenterMiami, FL
NCI Clinical
50.3
16
University of Illinois Cancer CenterChicago, IL
50.3
17
Cancer Center at IllinoisUrbana, IL
50.3
18
Tampa General Hospital Cancer InstituteTampa, FL
50.3

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →